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Dear Editor, 
 
We thank Kola and colleagues for their interest in our work titled ‘Clinical and laboratory 
predictors of deep vein thrombosis after acute stroke’ recently published in Thrombosis 
Research (1).  We are grateful for their thoughtful comments around the study methodology 
and data presentation (2).   
The debate regarding meaningful outcomes in venous thromboembolism (VTE) research is a 
longstanding one. We acknowledge the controversy on whether distal DVT is a valid 
surrogate outcome measure for symptomatic major VTE.  We must keep in mind the natural 
history of  DVT which usually arises from calf veins and may resolve spontaneously, or can 
propagate to proximal veins, with subsequent embolisation in pulmonary vasculature without 
necessarily manifesting clinically obvious symptoms (3-5).  The possible lack of classical 
symptoms of VTE informed our decision to choose asymptomatic DVT as the study outcome 
(1). 
We acknowledge Kola and colleagues’ comments regarding the methodology, particularly on 
the approach to creation of a prediction model. We set out to identify the relationship 
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between DVT and individual factors measured, including thrombin generation (a novel 
haemostatic marker), with subsequent aim of examining the independent role of identified 
factors on DVT prediction. This was achieved through logistic regression, with a stepwise 
process of backward selection to retain only statistically significant variables.   
Wells’ score was considered in our study design.  However, it was developed and validated 
as a tool for symptomatic DVT, not for screening asymptomatic patients (6).  Thus we 
selected simple, validated stroke severity and functional disability rating scales such as 
National Institute of Health Stroke Scale (NIHSS) and Barthel index (7-9), and thrombin 
generation, alongside D-dimer as clinical and laboratory factors respectively. 
In table 4, due to multimodal distribution of D-dimer, dichotomisation was undertaken, with 
subsequent adjustment for confounding variables. This step was necessary in view of dose 
dependent relationship identified between D-dimer and DVT.  The clinical variables shown 
were adjusted for age.  Similarly, D-dimer values at stated cut-points (50
th
, 75
th
 and 90
th 
centiles) were adjusted for age, BMI, Barthel index and NIHSS. We thank Kola et al for 
bringing to our attention discrepant p-values and confidence intervals within table 4. The 
original data has been reviewed and transcription errors identified which have been corrected 
in a corrigendum notice submitted to the Editor. 
We acknowledge that the study is limited by significant attrition due to strict exclusion 
criteria, thus limiting the effect of sample size on results. This is evident in the relatively high 
dispersion in sample distribution and wide confidence intervals observed.   
We suggest that using clinical VTE as a study outcome after stroke not only at risks of being 
confounding with common post stroke complications stated above, but also the risk of delays 
in establishing an objective diagnosis.  Also, whilst the discriminatory role of D-dimer in 
DVT is established, this has to be interpreted cautiously, especially in the aftermath of acute 
stroke (1, 10).  We concur that external validation of D-dimer in DVT prediction post stroke 
is required and acknowledge this in the original publication (1)  
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Table 4, Unadjusted and adjusted odds of association of clinical and laboratory 
predictors of DVT 
Outcome Unadjusted OR 
(95% CI) 
p-value Adjusted OR 
(95% CI) 
p-value. 
Age 3.11(1.70-4.10) 0.02 1.89 (0.67-6.69) 0.20 
BMI* 4.90 (1.87-6.66) 0.05 3.20 (0.97-4.89) 0.16† 
Barthel index** 5.1 (2.67-8.90) 0.018 4.2 (0.76- 8.40) 0.15† 
NIHSS*** 3.6 (1.03-9.11) 0.017 2.81 (0.73-8.33) 0.19† 
D-dimer1(Crude) 8.11 (1.90, 34.7) 0.005 -  
DD1 ≥1500ng/mL 
(median) 
4.10 (1.39-7.40) 0.006 2.95 (1.98-5.60) 0.005†† 
DD1 ≥4940ng/mL 
(75
th
 centile) 
5.82 (1.72-8.40) 0.003 3.98 (2.10-9.80) 0.005†† 
DD1 ≥7600ng/mL 
(90
th
 centile) 
6.91 (1.84-10.2) 0.005 3.4 (1.17-11.4) 0.003
††
 
Log DD2 4.32 (1.23-14.3) 0.03 3.9 (1.91-7.93) 0.02
††
 
DD2 >500ng/mL 5.3 (1.80-13.9) 0.004 3.45 (0.76-9.40) 0.17
††
 
OR, odds ratio; CI, confidence interval; BMI, body mass index; DD1, D-dimer (baseline) time 1; DD2, D-dimer (week 2) time 2; NIHSS, 
National Institute of Health Stroke Scale; (*) per 10mg/kg 2 increase in BMI;(**) per 4 unit decrease in Barthel index; (***) per 4 unit 
increase in NIHSS; (†) adjusted for age, per 10 year increase in age, (††) adjusted for age, NIHSS, BMI, Barthel index; Log, 
logarithm [analysis was on the log scale (base 10)]. 
